Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Krah

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Biological Chemistry|February 19, 2024
Bovine ultralong CDR-H3 derived knob paratopes elicit potent TNF-α neutralization and enable the generation of novel adalimumab-based antibody architectures with augmented featuresPaul Arras, Jasmin Zimmermann, Britta Lipinski, et al.
Iscience|April 9, 2026
Antigen-directed single domain antibody-based TNFR1 agonists elicit preferential killing of HER2-overexpressing cancer cellsLaura Unmuth, Britta Lipinski, Alicia Hoerr, et al.
The Journal of Biological Chemistry|October 4, 2016
Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) × c-MET Antibodies and Antibody-Drug ConjugatesCarolin Sellmann, Achim Doerner, Christine Knuehl, et al.
Frontiers in Molecular Biosciences|October 16, 2023
AI/ML combined with next-generation sequencing of VHH immune repertoires enables the rapid identification of <i>de novo</i> humanized and sequence-optimized single domain antibodies: a prospective case studyPaul Arras, Han Byul Yoo, Lukas Pekar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2022
Multifunctional NK Cell-Engaging Antibodies Targeting EGFR and NKp30 Elicit Efficient Tumor Cell Killing and Proinflammatory Cytokine ReleaseKatja Klausz, Lukas Pekar, Ammelie Svea Boje, et al.
Mabs|February 19, 2024
Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagersAmmelie Svea Boje, Lukas Pekar, Katharina Koep, et al.
Mabs|July 20, 2023
Generation and engineering of potent single domain antibody-based bispecific IL-18 mimetics resistant to IL-18BP decoy receptor inhibitionBritta Lipinski, Laura Unmuth, Paul Arras, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2020
Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 EngagementLukas Pekar, Katja Klausz, Michael Busch, et al.
International Journal of Molecular Sciences|February 24, 2024
A Generic Approach for Miniaturized Unbiased High-Throughput Screens of Bispecific Antibodies and Biparatopic Antibody-Drug ConjugatesNadine Barron, Stephan Dickgiesser, Markus Fleischer, et al.
Protein Science : a Publication of the Protein Society|February 21, 2025
Taming interleukin-12: Engineering of bispecific antibody-based IL-12 mimetics with biased agonism capacitiesBritta Lipinski, Laura Unmuth, Paul Arras, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Biological Chemistry|February 19, 2024
Bovine ultralong CDR-H3 derived knob paratopes elicit potent TNF-α neutralization and enable the generation of novel adalimumab-based antibody architectures with augmented featuresPaul Arras, Jasmin Zimmermann, Britta Lipinski, et al.
Iscience|April 9, 2026
Antigen-directed single domain antibody-based TNFR1 agonists elicit preferential killing of HER2-overexpressing cancer cellsLaura Unmuth, Britta Lipinski, Alicia Hoerr, et al.
The Journal of Biological Chemistry|October 4, 2016
Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) × c-MET Antibodies and Antibody-Drug ConjugatesCarolin Sellmann, Achim Doerner, Christine Knuehl, et al.
Frontiers in Molecular Biosciences|October 16, 2023
AI/ML combined with next-generation sequencing of VHH immune repertoires enables the rapid identification of <i>de novo</i> humanized and sequence-optimized single domain antibodies: a prospective case studyPaul Arras, Han Byul Yoo, Lukas Pekar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2022
Multifunctional NK Cell-Engaging Antibodies Targeting EGFR and NKp30 Elicit Efficient Tumor Cell Killing and Proinflammatory Cytokine ReleaseKatja Klausz, Lukas Pekar, Ammelie Svea Boje, et al.
Mabs|February 19, 2024
Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagersAmmelie Svea Boje, Lukas Pekar, Katharina Koep, et al.
Mabs|July 20, 2023
Generation and engineering of potent single domain antibody-based bispecific IL-18 mimetics resistant to IL-18BP decoy receptor inhibitionBritta Lipinski, Laura Unmuth, Paul Arras, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2020
Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 EngagementLukas Pekar, Katja Klausz, Michael Busch, et al.
International Journal of Molecular Sciences|February 24, 2024
A Generic Approach for Miniaturized Unbiased High-Throughput Screens of Bispecific Antibodies and Biparatopic Antibody-Drug ConjugatesNadine Barron, Stephan Dickgiesser, Markus Fleischer, et al.
Protein Science : a Publication of the Protein Society|February 21, 2025
Taming interleukin-12: Engineering of bispecific antibody-based IL-12 mimetics with biased agonism capacitiesBritta Lipinski, Laura Unmuth, Paul Arras, et al.
Pageof 5